[RFA-HG-27-012] GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

Description

Titolo: GREGoRi Technology Integration Center (U01, Clinical Trials Optional) Numero dell'opportunità: RFA-HG-27-012 Stato: aperto (posted) Tipo di opportunità: Discretionary Ente: National Institutes of Health — Department of Health and Human Services Tipo di finanziamento: Cooperative Agreement Categoria: Health Programma (ALN): 93.172 Human Genome Research Pubblicato il: 2026-06-18 Scadenza per le domande: 2026-10-30 Importo massimo per progetto: 2,250,000 USD Finanziamento totale stimato: 3,000,000 USD Numero di finanziamenti attesi: 1 Cofinanziamento richiesto: no Chi può fare domanda: Small businesses; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts; Public and State controlled institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; Special district governments; Native American tribal governments (Federally recognized); City or township governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; County governments Altre condizioni di eleggibilità: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Descrizione: The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this Notice of Funding Opportunity is to establish the GREGoRi Technology Integration Center, which will enable the development of standards and best practices for applying new and emerging molecular methods in rare disease diagnosis. A major deliverable of the Center will be a multidimensional dataset that can be used for the development and benchmarking of novel tools and strategies that facilitate rare disease diagnosis. Contatto: [email protected]

Sectors

Source

Source: grants.gov